Prime Medicine (PRME) EBT Margin (2024 - 2026)

Prime Medicine (PRME) reported EBT Margin of 5798.25% for Q1 2026, down 222947.0% on a YoY basis from N/an in Q1 2025, and down 2.24% quarter-over-quarter from 5671.24% in Q4 2025.

Prime Medicine (PRME) EBT Margin (2024 - 2026) Analysis & Trends

Prime Medicine has reported EBT Margin for 3 years, with the latest figure at 5798.25% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 222947.0% year-over-year to 5798.25%; the trailing twelve-month figure through Mar 2026 stood at 5021.84% (up 23414.0% YoY), and the FY2025 full-year result was 4408.48%, up 215813.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 5798.25%, down from 5671.24% in the prior quarter.
  • The five-year high for EBT Margin was 1936.6% in Q4 2024, with the low at 25128.23% in Q3 2024.
  • Historically, EBT Margin has averaged 7356.61% across 3 years, with a median of 5193.96% in 2025.
  • The largest YoY upside for EBT Margin was 2081541 bps in 2025 against a maximum downside of 373464 bps in 2025.
  • Prime Medicine's EBT Margin stood at 1936.6% in 2024, then tumbled by 193 bps to 5671.24% in 2025, then decreased by 2 bps to 5798.25% in 2026.
  • The last three EBT Margin figures came in at 5798.25% (Q1 2026), 5671.24% (Q4 2025), and 4312.82% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prime Medicine 572.02 Mn 572.02 Mn - -5,798.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,798.25%
Dec 31, 2025 -5,671.24%
Sep 30, 2025 -4,312.82%
Jun 30, 2025 -4,716.68%
Mar 31, 2025 -3,568.78%
Dec 31, 2024 -1,936.60%
Sep 30, 2024 -25,128.23%
Mar 31, 2024 -7,720.30%